Epilobium angustifolium L. as a Potential Herbal Component of Topical Products for Skin Care and Treatment-A Review

Molecules. 2022 May 31;27(11):3536. doi: 10.3390/molecules27113536.

Abstract

Epilobium angustifolium L. (EA) has been used as a topical agent since ancient times. There has been an increasing interest in applying EA as a raw material used topically in recent years. However, in the literature, there are not many reports on the comprehensive application of this plant to skin care and treatment. EA contains many valuable secondary metabolites, which determine antioxidant, anti-inflammatory, anti-aging, and antiproliferative activity effects. One of the most important active compounds found in EA is oenothein B (OeB), which increases the level of ROS and protects cells from oxidative damage. OeB also influences wound healing and reduces inflammation by strongly inhibiting hyaluronidase enzymes and inhibiting COX-1 and COX-2 cyclooxygenases. Other compounds that play a key role in the context of application to the skin are flavonoids, which inhibit collagenase and hyaluronidase enzymes, showing anti-aging and anti-inflammatory properties. While terpenes in EA play an important role in fighting bacterial skin infections, causing, among other things cell membrane, permeability increase as well as the modification of the lipid profiles and the alteration of the adhesion of the pathogen to the animal cells. The available scientific information on the biological potential of natural compounds can be the basis for the wider use of EA in skin care and treatment. The aim of the article is to review the existing literature on the dermocosmetic use of E. angustifolium.

Keywords: Epilobium angustifolium L.; anti-aging; anti-inflammatory; antioxidant; cosmetics; skin.

Publication types

  • Review

MeSH terms

  • Animals
  • Anti-Inflammatory Agents / pharmacology
  • Epilobium*
  • Hyaluronoglucosaminidase
  • Onagraceae*
  • Plant Extracts / pharmacology
  • Skin Care

Substances

  • Anti-Inflammatory Agents
  • Plant Extracts
  • Hyaluronoglucosaminidase

Grants and funding

This research received no external funding.